Zsofia Kuronya
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Multicentric Comprehensive Clinical, Pathological, and Molecular Analysis of 12 Cases.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: December 17, 2025
First results of comprehensive genomic studies on solid tumours in National Institute of Oncology
Journal: Magyar onkologia
Published: February 12, 2025
Impact of comprehensive genomic profiling on the diagnosis and clinical management of malignant mesenchymal tumours.
Journal: Pathology oncology research : POR
Published: December 23, 2024
Representation of geriatric oncology in cancer care guidelines in Europe: a scoping review by the International Society of Geriatric Oncology (SIOG).
Journal: ESMO open
Published: November 29, 2024
Metastatic Prostatic Adenocarcinoma to the Penis with Diffuse P16 Expression: Recognizing a Diagnostic Pitfall.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: November 29, 2024
The effect of PSMA PET/CT performed in primary staging on the clinical decision
Journal: Magyar onkologia
Published: October 16, 2024
Mutation frequency of homologous recombination repair genes in prostate adenocarcinomas
Journal: Magyar onkologia
Published: April 29, 2024
First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.
Journal: Cancer immunology, immunotherapy : CII
Published: April 01, 2024
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Journal: Cancer immunology, immunotherapy : CII
Published: April 01, 2024
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1).
Journal: Cancer immunology, immunotherapy : CII
Published: March 18, 2024
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Journal: Cancer immunology, immunotherapy : CII
Published: February 05, 2024
Application of comprehensive molecular genetic profiling in precision cancer medicine, Hungarian experiences.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 19, 2024
Last Updated: 09/26/2026